Skip to main content
. Author manuscript; available in PMC: 2012 May 21.
Published in final edited form as: Anticancer Agents Med Chem. 2011 Feb;11(2):202–212. doi: 10.2174/187152011795255957

Fig. (3).

Fig. (3)

Survival Curves: Effect of MnTnHex-2-PyP5+ treatment on the survival of mice bearing intracranial human pediatric medulloblastoma D-341 MED xenografts. MnTnHex-2-PyP5+ was given sc at a dose of 1.6 mg/kg b.i.d. throughout the duration of experiment.